Literature DB >> 11145915

Characterization of cell-surface determinants important for baculovirus infection.

H Tani1, M Nishijima, H Ushijima, T Miyamura, Y Matsuura.   

Abstract

Baculovirus gp64 envelope glycoprotein is a major component of the envelope of the budded virus and is involved in virus entry into the host cells by endocytosis. To investigate the cell-surface molecules important for infection of baculovirus into mammalian cells, we constructed a recombinant baculovirus, Ac64-CAluc, which has gp64 and luciferase genes under the polyhedrin and the CAG promoter, respectively. For controls, we constructed recombinant viruses possessing vesicular stomatitis virus (VSV) G protein, mouse hepatitis virus (MHV) S protein, or green fluorescent protein (GFP) gene under the polyhedrin promoter and the luciferase gene under the CAG promoter (AcVSVG-CAluc, AcMHVS-CAluc, and AcGFP-CAluc). Treatment of HepG2 cells with phospholipase C markedly reduced the reporter gene expression by Ac64-CAluc or AcVSVG-CAluc in a dose-dependent manner, whereas AcMHVS-CAluc was shown to be resistant to the treatment. Inhibition with purified lipids and susceptibility to the mutant CHO hamster cell lines deficient in phospholipids synthesis suggest that the interaction of gp64 and phospholipids on the cell surface might play an important role in baculovirus infection into mammalian cells. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145915     DOI: 10.1006/viro.2000.0699

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  48 in total

Review 1.  Baculovirus as a vaccine vector.

Authors:  Hsin-Yu Lu; Yi-Hsuan Chen; Hung-Jen Liu
Journal:  Bioengineered       Date:  2012-06-18       Impact factor: 3.269

2.  Innate immune response induced by baculovirus attenuates transgene expression in mammalian cells.

Authors:  Chikako Ono; Akinori Ninomiya; Satomi Yamamoto; Takayuki Abe; Xiauyu Wen; Takasuke Fukuhara; Miwa Sasai; Masahiro Yamamoto; Tatsuya Saitoh; Takashi Satoh; Taro Kawai; Ken J Ishii; Shizuo Akira; Toru Okamoto; Yoshiharu Matsuura
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

3.  Rapid expression of recombinant proteins in modified CHO cells using the baculovirus system.

Authors:  Luciano Ramos; Lisa A Kopec; Sharon M Sweitzer; James A Fornwald; Huizhen Zhao; Paul McAllister; Dean E McNulty; John J Trill; James F Kane
Journal:  Cytotechnology       Date:  2002-01       Impact factor: 2.058

4.  High-density cultivation of insect cells and production of recombinant baculovirus using a novel oscillating bioreactor.

Authors:  Yu-Chen Hu; Jen-Te Lu; Yao-Chi Chung
Journal:  Cytotechnology       Date:  2003-09       Impact factor: 2.058

5.  Development of Rous sarcoma Virus-like Particles Displaying hCC49 scFv for Specific Targeted Drug Delivery to Human Colon Carcinoma Cells.

Authors:  Tatsuya Kato; Megumi Yui; Vipin Kumar Deo; Enoch Y Park
Journal:  Pharm Res       Date:  2015-06-06       Impact factor: 4.200

6.  Baculovirus entry into human hepatoma cells.

Authors:  Heli Matilainen; Johanna Rinne; Leona Gilbert; Varpu Marjomäki; Hilkka Reunanen; Christian Oker-Blom
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

7.  Transgene expression in Penaeus monodon cells: evaluation of recombinant baculoviral vectors with shrimp specific hybrid promoters.

Authors:  Jayesh Puthumana; Rosamma Philip; I S Bright Singh
Journal:  Cytotechnology       Date:  2015-05-17       Impact factor: 2.058

8.  Baculovirus mediated transduction: analysis of vesicular stomatitis virus glycoprotein pseudotyping.

Authors:  Sujit M Kolangath; S H Basagoudanavar; M Hosamani; P Saravanan; R P Tamil Selvan
Journal:  Virusdisease       Date:  2014-10-11

9.  Display of heterologous proteins on gp64null baculovirus virions and enhanced budding mediated by a vesicular stomatitis virus G-stem construct.

Authors:  Jian Zhou; Gary W Blissard
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

10.  Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64.

Authors:  Yuuki Kaname; Hideki Tani; Chikako Kataoka; Mai Shiokawa; Shuhei Taguwa; Takayuki Abe; Kohji Moriishi; Taroh Kinoshita; Yoshiharu Matsuura
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.